Volume 5, Issue 3, Pages (September 1996)

Slides:



Advertisements
Similar presentations
CD4+CD25+ Immunoregulatory T Cells
Advertisements

Pancreatic Lymph Node-Derived CD4+CD25+ Treg Cells
Volume 133, Issue 5, Pages (November 2007)
Differentiation of CD4+ T Cells to Th1 Cells Requires MAP Kinase JNK2
Thymic Selection by a Single MHC/Peptide Ligand
Ting-ting Zhang, MSc, Klaus Okkenhaug, PhD, Baher F
Macrophages from C3-deficient mice have impaired potency to stimulate alloreactive T cells by Wuding Zhou, Hetal Patel, Ke Li, Qi Peng, Marie-Bernadette.
Volume 31, Issue 2, Pages (August 2009)
Volume 15, Issue 1, Pages (July 2001)
Volume 29, Issue 6, Pages (December 2008)
Volume 20, Issue 4, Pages (April 2004)
Durbaka V.R Prasad, Sabrina Richards, Xoi Muoi Mai, Chen Dong  Immunity 
Volume 18, Issue 5, Pages (May 2003)
Volume 21, Issue 1, Pages (July 2004)
Local Expression of TNFα in Neonatal NOD Mice Promotes Diabetes by Enhancing Presentation of Islet Antigens  E.Allison Green, Elizabeth E. Eynon, Richard.
Mechanism Underlying Counterregulation of Autoimmune Diabetes by IL-4
Volume 4, Issue 4, Pages (October 2008)
Volume 6, Issue 4, Pages (April 1997)
Volume 4, Issue 3, Pages (March 1996)
Mark H Kaplan, Ulrike Schindler, Stephen T Smiley, Michael J Grusby 
NKT Cells Inhibit the Onset of Diabetes by Impairing the Development of Pathogenic T Cells Specific for Pancreatic β Cells  Lucie Beaudoin, Véronique.
Maturation, Ag presentation capacity, and IL-12 production of DCs
Volume 24, Issue 3, Pages (March 2006)
Volume 10, Issue 9, Pages (March 2015)
James I Kim, I-Cheng Ho, Michael J Grusby, Laurie H Glimcher  Immunity 
Impaired Development of Th2 Cells in IL-13-Deficient Mice
Impaired Th2 Subset Development in the Absence of CD4
Volume 29, Issue 6, Pages (December 2008)
Volume 34, Issue 1, Pages (January 2011)
Down-Regulation of IL-4 Gene Transcription and Control of Th2 Cell Differentiation by a Mechanism Involving NFAT1  Alexander Kiani, João P.B Viola, Andrew.
E.Allison Green, Richard A Flavell  Immunity 
T Cell-Produced Transforming Growth Factor-β1 Controls T Cell Tolerance and Regulates Th1- and Th17-Cell Differentiation  Ming O. Li, Yisong Y. Wan, Richard.
Volume 15, Issue 1, Pages (July 2001)
NKG2D Blockade Prevents Autoimmune Diabetes in NOD Mice
Volume 19, Issue 5, Pages (November 2003)
C5a Negatively Regulates Toll-like Receptor 4-Induced Immune Responses
Volume 16, Issue 2, Pages (February 2002)
Volume 33, Issue 4, Pages (October 2010)
Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease  Leonid Gorelik, Richard A Flavell  Immunity 
Volume 19, Issue 3, Pages (September 2003)
Impaired Development of Th2 Cells in IL-13-Deficient Mice
T Cell–Mediated Elimination of B7.2 Transgenic B Cells
Volume 135, Issue 3, Pages (September 2008)
Volume 9, Issue 5, Pages (November 1998)
Volume 18, Issue 3, Pages (March 2003)
CD40, but Not CD40L, Is Required for the Optimal Priming of T Cells and Control of Aerosol M. tuberculosis Infection  Vanja Lazarevic, Amy J Myers, Charles.
CTLA-4 Regulates Induction of Anergy In Vivo
T Cells with Low Avidity for a Tissue-Restricted Antigen Routinely Evade Central and Peripheral Tolerance and Cause Autoimmunity  Dietmar Zehn, Michael.
Volume 15, Issue 2, Pages (August 2001)
Impairment of NK Cell Function by NKG2D Modulation in NOD Mice
In Vivo Expansion of Regulatory T cells With IL-2/IL-2 mAb Complexes Prevents Anti- factor VIII Immune Responses in Hemophilia A Mice Treated With Factor.
Volume 14, Issue 5, Pages (May 2001)
Johannes Hampl, Yueh-hsiu Chien, Mark M Davis  Immunity 
Antigen-specific and nonspecific determinants of cytokine production during topical sensitization of mice to chemical allergens  Artin Moussavi, PhDa,
Protective Regulatory T Cell Generation in Autoimmune Diabetes by DNA Covaccination with Islet Antigens and a Selective CTLA-4 Ligand  Yelena Glinka,
Toll-Dependent Control Mechanisms of CD4 T Cell Activation
Volume 25, Issue 12, Pages e5 (December 2018)
Mechanism Underlying Counterregulation of Autoimmune Diabetes by IL-4
Volume 31, Issue 6, Pages (December 2009)
Volume 38, Issue 3, Pages (March 2013)
Volume 15, Issue 4, Pages (October 2001)
Volume 6, Issue 5, Pages (May 1997)
Volume 24, Issue 6, Pages (June 2006)
Epicutaneous Immunization with Autoantigenic Peptides Induces T Suppressor Cells that Prevent Experimental Allergic Encephalomyelitis  Margaret S. Bynoe,
Volume 8, Issue 5, Pages (May 1998)
Volume 13, Issue 11, Pages (December 2015)
Thymocyte Glucocorticoid Resistance Alters Positive Selection and Inhibits Autoimmunity and Lymphoproliferative Disease in MRL-lpr/lprMice  Eva Tolosa,
Volume 4, Issue 5, Pages (May 1996)
Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease  Leonid Gorelik, Richard A Flavell  Immunity 
Volume 10, Issue 3, Pages (March 1999)
Presentation transcript:

Volume 5, Issue 3, Pages 285-293 (September 1996) CD28/B7 Regulation of Th1 and Th2 Subsets in the Development of Autoimmune Diabetes  Deborah J Lenschow, Kevan C Herold, Lesley Rhee, Bina Patel, Ann Koons, Hui-Yu Qin, Elaine Fuchs, Bhagarith Singh, Craig B Thompson, Jeffrey A Bluestone  Immunity  Volume 5, Issue 3, Pages 285-293 (September 1996) DOI: 10.1016/S1074-7613(00)80323-4

Figure 1 CTLA-4Ig Tg+ NOD Mice Display an Increased Incidence of Disease The CTLA-4Ig Tg mouse was bred onto the NOD mouse as described in Experimental Procedures. Both the CTLA-4Ig Tg+ NOD mice (n = 5) and the Tg− NOD mice (n = 12) were monitored for 24 weeks for the development of diabetes by measuring weekly blood glucose levels. Immunity 1996 5, 285-293DOI: (10.1016/S1074-7613(00)80323-4)

Figure 2 Increased Onset and Incidence of Diabetes in CD28−/− NOD Mice CD28−/− mice were bred onto the NOD background for four generations as described in the Experimental Procedures. Beginning at 10 weeks of age, blood glucose levels of female (left) and male (right) mice were checked weekly. CD28+/+ mice are represented by open circles (male: n = 16), CD28+/− mice by open squares (male: n = 32; female: n = 11), and CD28−/− by solid circles (male: n = 21; female: n = 12). Immunity 1996 5, 285-293DOI: (10.1016/S1074-7613(00)80323-4)

Figure 3 T Cells from the CD28−/− NOD Mice Respond to the Autoantigen GAD, but Do Not Respond to Physiological Antigen Challenge (A) Proliferation to anti-CD3 mAb [145-2C11] was measured following stimulation of splenic T cells isolated from 10 week old CD28+/+ (solid circles), CD28+/− (solid squares), or CD28−/− (solid diamonds) NOD mice for 48 hr with soluble mAb in the presence of Fc receptor–positive antigen-presenting cells. (B) Proliferation to OVA was measured using lymph node cells isolated from CD28+/− NOD mice (solid squares) and CD28−/− NOD mice (solid triangles) that had been immunized in vivo 7 days previously. (C) Splenic T cells from CD28+/+ (solid bars), CD28+/− (shaded bars), or CD28−/− (cross-hatched bars) NOD mice were stimulated with either anti-CD3 (10 μg/ml), OVA (100 μg/ml), or GAD65 (10 μg/ml). Supernatants were collected at 24 hr and analyzed for IL-2 by ELISA. The results presented are the average of 2–4 mice per group and are representative of three independent experiments. NT, not tested. Immunity 1996 5, 285-293DOI: (10.1016/S1074-7613(00)80323-4)

Figure 3 T Cells from the CD28−/− NOD Mice Respond to the Autoantigen GAD, but Do Not Respond to Physiological Antigen Challenge (A) Proliferation to anti-CD3 mAb [145-2C11] was measured following stimulation of splenic T cells isolated from 10 week old CD28+/+ (solid circles), CD28+/− (solid squares), or CD28−/− (solid diamonds) NOD mice for 48 hr with soluble mAb in the presence of Fc receptor–positive antigen-presenting cells. (B) Proliferation to OVA was measured using lymph node cells isolated from CD28+/− NOD mice (solid squares) and CD28−/− NOD mice (solid triangles) that had been immunized in vivo 7 days previously. (C) Splenic T cells from CD28+/+ (solid bars), CD28+/− (shaded bars), or CD28−/− (cross-hatched bars) NOD mice were stimulated with either anti-CD3 (10 μg/ml), OVA (100 μg/ml), or GAD65 (10 μg/ml). Supernatants were collected at 24 hr and analyzed for IL-2 by ELISA. The results presented are the average of 2–4 mice per group and are representative of three independent experiments. NT, not tested. Immunity 1996 5, 285-293DOI: (10.1016/S1074-7613(00)80323-4)

Figure 4 Expression of IFNγ and IL-4 mRNA by Intrapancreatic Cells Isolated from CD28−/− and CD28+/− NOD Mice Intrapancreatic cells were isolated from 8-week-old normoglycemic CD28−/− NOD mice (KO) and CD28+/− NOD mice (Htz) from the same backcross generation as described in Experimental Procedures. RNA and cDNA were prepared, and equivalent amounts of cDNA (based on analysis of HPRT) were used for competitive RT–PCR studies of IFNγ and IL-4 gene expression as described (Reiner et al. 1993). C, competitor, W, wild-type products. The size of the PCR products were as follows: IFNγ: C = 300 amino acids, W = 234 amino acids; IL-4: C = 360 amino acids, W = 240 amino acids; HPRT: C = 450 amino acids, W = 352 amino acids. This result is representative of two independent experiments. Immunity 1996 5, 285-293DOI: (10.1016/S1074-7613(00)80323-4)

Figure 5 CD28−/− NOD Mice Produce a Diminished Th2 Response Following In Vitro Stimulation Splenic T cells from CD28+/+ (solid bars), CD28+/− (shaded bars), or CD28−/− (cross−hatched bars) NOD mice were stimulated with GAD65 and then restimulated with 145-2C11. Supernatants were then harvested 48 hr later and examined for the presence of IL-4 and IFNγ. Two independent experiments are shown. The results are the average of four mice per groups. Immunity 1996 5, 285-293DOI: (10.1016/S1074-7613(00)80323-4)

Figure 6 Isotypic Analysis of Anti-GAD Antibodies Produced in CD28−/− NOD Mice Sera from 8–10-week-old CD28−/− NOD mice (cross-hatched bars) and CD28+/− NOD mice (shaded bars) were collected and analyzed by ELISA for the presence of anti-GAD67 antibodies of the IgG1 and IgG2a isotypes as described in the Experimental Procedures. Immunity 1996 5, 285-293DOI: (10.1016/S1074-7613(00)80323-4)